Aamir Saifuddin

COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study

James L. Alexander, Nicholas A. Kennedy, Hajir Ibraheim et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 149 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

Simeng Lin, Nicholas A. Kennedy, Aamir Saifuddin et al. · Nature Communications · 2022 · 81 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study

James L. Alexander, Zhigang Liu, Diana Mūnoz Sandoval et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 67 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients

James L. Alexander, Benjamin H. Mullish, Nathan Danckert et al. · EBioMedicine · 2023 · 58 citations · Full text

Life Sciences, Immunology, Microbiology +17

Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study

Shaji Sebastian, G Walker, Nicholas A. Kennedy et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 38 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15